Acelity said Wednesday it won a 5-year National Blanket Purchase Agreement with the Department of Veterans Affairs to supply it with negative pressure wound therapy supplies and devices.
Through the deal, San Antonio, Texas-based Acelity will supply the VA with devices that help promote wound healing for acute and chronic wounds.
“Deep wounds caused by acute injuries and chronic wounds that may occur as a result of prolonged bed occupancy or a serious chronic condition like diabetes require specialized care to help prevent infections, potential tissue necrosis, and limb-loss. Advanced wound therapy is critically important to our nation’s veterans – both active and retired,” Peacehealth Southwest Medical Center department of plastic surgery chief Dr. Allen Gabriel said in prepared remarks.
The deal includes the company’s V.A.C. Ulta and InfoV.A.C. therapy systems as leased standard devices, the ActiV.A.C. therapy system as a leased lightweight device and the V.A.C. Via therapy system as a disposable device, the company said.
“This agreement with the VA will provide access to Acelity’s comprehensive portfolio of V.A.C. therapy systems, and allow us to continue offering our veterans solutions which have been proven in clinical studies to speed healing and lower the total overall cost of care compared to standard wound dressings. Our products are the gold standard in negative pressure wound therapy, and our work with the VA under this agreement recognizes that,” Acelity business and innovation group prez Gaurav Agarwal in a press release.
In June, Acelity was reportedly considering an initial public offering that could fetch up to $1 billion as its private equity owners look to pay down debt. The IPO proceeds would be used to pay down the $4.8 million in long-term debt Acelity is carrying, unnamed sources told the Wall Street Journal.